FDA clears AngioScores balloon catheter for renal indications

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
AngioScore, a developer of angioplasty catheters for use in the treatment of cardiovascular disease, has received 510(k) clearance from the FDA to market its AngioSculpt PTA scoring balloon catheter for dilatation of lesions in renal arteries.

AngioScore previously had received 510(k) clearance to market the AngioSculpt device for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal and infra-popliteal arteries, as well as for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae, according to the Fremont, Calif.-based company. This new 510(k) clearance adds renal arteries to the indications for use statement.

Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.